P/E at 60.74 vs Industry's 60.64: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Parity?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 60.74, marginally above the hospital industry average of 60.64. This near-equal valuation level indicates that the market is pricing the company in line with its sector peers, reflecting neither a significant premium nor a discount. Such a valuation suggests that investors are factoring in the company’s growth prospects and risk profile similarly to the broader hospital industry. The market cap of ₹1,18,650.38 crores classifies it firmly as a large-cap stock, reinforcing its stature within the sector.

However, the P/E ratio remains elevated compared to many other sectors, underscoring the premium typically accorded to healthcare companies with steady earnings growth. This valuation context raises the question previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside performance and technical indicators.

Performance Across Timeframes: Sustained Outperformance

Examining the stock’s returns reveals a consistent outperformance relative to the Sensex across multiple periods. Over one year, Apollo Hospitals delivered a 17.02% gain, contrasting with the Sensex’s 6.81% loss. The year-to-date return of 17.17% similarly outshines the Sensex’s -10.82%, indicating resilience amid broader market weakness.

Shorter-term returns also reflect positive momentum. The three-month return of 5.52% surpasses the Sensex’s -6.51%, while the one-month gain of 5.53% and one-week increase of 1.89% further confirm recent strength. Even the one-day performance, though slightly negative at -0.09%, marginally underperformed the Sensex’s -0.02%. This short-term dip follows two consecutive days of losses, amounting to a 2.13% decline, which may be a minor correction within a broader uptrend — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Technical Insights

The technical picture for Apollo Hospitals Enterprise Ltd. is revealing. The stock currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, signalling a sustained medium- to long-term uptrend. However, it remains below its 5-day moving average, indicating some short-term selling pressure or consolidation. This configuration suggests that while the immediate momentum has softened, the overall trend remains positive.

Trading just 3.21% below its 52-week high of ₹8,490.3, the stock is close to its peak levels for the past year. The opening price of ₹8,225.95 on the latest trading day has held steady, despite the slight intraday weakness. This juxtaposition of short-term softness against longer-term strength invites the question is this a one-quarter anomaly or the start of a structural revenue problem? The moving average alignment provides a useful lens to assess whether the recent dip is temporary or indicative of a deeper trend reversal.

Sector Performance Context

The hospital sector, to which Apollo Hospitals belongs, has shown mixed results recently. While some companies have experienced flat or negative returns, Apollo Hospitals stands out with consistent positive returns across multiple timeframes. This relative strength within the sector highlights its leadership position and operational resilience.

Given the sector’s typical valuation range, the company’s P/E ratio aligns closely with peers, suggesting that the market views its growth and risk profile as comparable. This balance between valuation and performance is a key factor in understanding the stock’s current market standing.

Rating Reassessment and Historical Context

Previously rated Hold by MarketsMOJO, Apollo Hospitals Enterprise Ltd. had its rating reassessed on 11 May 2026. The current Mojo Score stands at 78.0, reflecting a positive evaluation across multiple parameters. This reassessment comes amid strong multi-year returns, with the stock delivering 79.00% over three years, 158.26% over five years, and an impressive 513.09% over ten years, all significantly outperforming the Sensex over the same periods.

Such long-term outperformance underscores the company’s sustained growth trajectory and market leadership. The rating update likely incorporates these factors alongside recent valuation and technical data — should investors in Apollo Hospitals hold, buy more, or reconsider?

Consolidated View: What the Data Collectively Shows

The data for Apollo Hospitals Enterprise Ltd. reveals a stock trading at a valuation closely aligned with its industry peers, supported by robust multi-year returns and a positive medium-term performance trend. The moving average configuration indicates a healthy uptrend, albeit with some short-term consolidation below the 5-day moving average. This suggests that while the stock has experienced minor recent weakness, the broader trend remains intact.

Its consistent outperformance relative to the Sensex across one month, three months, one year, and longer periods highlights its resilience in a challenging market environment. The reassessment of its rating from Hold to a more favourable stance reflects these underlying strengths, though the exact current rating remains undisclosed.

Investors may find value in analysing whether the recent short-term softness is a temporary pause or a signal of deeper shifts in momentum — what is the current rating?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →